Tumor-infiltrating immune cells: Triggers for tumor capsule disruption and tumor progression?

International Journal of Medical Sciences

Volumn 10, Issue 5, 2013, Pages 475-497

  Jiang, Bin ^a   Mason, Jeffrey ^b   Jewett, Anahid ^c   Liu, Min Ling ^b   Chen, Wen ^b   Qian, Jun ^a   Ding, Yijiang ^a   Ding, Shuqing ^a   Ni, Min ^a   Zhang, Xichen ^d   Man, Yan Gao ^d,e  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JILIN UNIVERSITY   (China)

^e Henry Jackson Foundation   (United States)

Author keywords

Colorectal cancer; Lymphocyte aggregates; Metastasis; Tumor capsule; Tumor invasion

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BASEMENT MEMBRANE DISRUPTION; BLOOD VESSEL; CANCER STEM CELL; CELL BUDDING; CELL INFILTRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE COURSE; EPITHELIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LYMPH FOLLICLE; LYMPH VESSEL; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; METASTASIS; MUSCULARIS MUCOSA FRAGMENTATION; STROMA; TISSUE SECTION; TUMOR CAPSULE DISRUPTION; TUMOR GROWTH;

COLORECTAL CANCER; METASTASIS, LYMPHOCYTE AGGREGATES.; TUMOR CAPSULE; TUMOR INVASION;

CELL AGGREGATION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; LEUKOCYTES; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84874987270     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5798     Document Type: Article

References (71)

1. Topalian SL, Solomon D, Rosenberg SA. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol. 1989; 142(10):3714-25.
2. Baxevanis CN, Dedoussis GV. Papadopoulos NG, Missitzis I,Stathopoulos GP, Papamichail M. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer. 1994; 74:1275-82.
3. Chen LJ, Zheng X, Shen YP et al. Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer. Cancer Immunol Immunother. 2012; [Epub ahead of print].
4. Milne K, Alexander C, Webb JR et al. Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J Transl Med. 2012 Feb 27;10:33.
5. Gannot G, Gannot I, Vered H, Buchner A, Keisaris Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratiosis to dysplasia and carcinoma. Br J Cancer. 2002; 86: 1444-8.
6. MacLennan GT, Eisenberg R, Fleshman RL et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol. 2006; 176: 1012-6.
7. Smith CJ, Gardner WA. Jr. Inflammation-proliferation: possible relationships in the prostate. Prog Clin Biol Res. 1987; 239: 317-25.
8. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4: 71-8.
9. Wyckoff J, Wang W, Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004; 64: 7022-9.
10. Pawelek JM, Chakraborty AK. The cancer cell--leukocyte fusion theory of metastasis. Adv Cancer Res. 2008; 101: 397-444.
11. De Narddo DG, Johansson M, Coussens LM. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev. 2008; 27: 11-8.
12. Eiró N, Vizoso FJ. Inflammation and cancer. World J Gastrointest Surg. 2012; 4(3):62-2.
13. Lazaris ACh, Tzoumani AN, Thimara I et al. Immunohistochemical assessment of basement membrane components in colorectal cancer: prognostic implications. J Exp Clin Cancer Res.2003; 22(4): 599-606.
14. Ambiru S, Miyazaki M, Ito H, et al. Type IV collagenase activities in human colorectal cancers and its role in cancer invasion and metastasis. Nihon Shokakibyo Gakkai Zasshi. 1993;90(7): 1555-61.
15. Hagedorn EJ, Sherwood DR. Cell invasion through basement membrane: the anchor cell breaches the barrier. Curr Opin Cell Biol. 2011; 23(5):589-96.
16. Mayadas TN, Tsokos GC, Tsuboi N. Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation. 2009; 120(20):2012-24.
17. Waterhouse NJ, Clarke CJ, Sedelies KA, Teng MW, Trapani JA. Cytotoxic lymphocytes; instigators of dramatic target cell death. Biochem Pharmacol.2004; 68(6):1033-40.
18. Cullen SP, Brunet M, Martin SJ. Granzymes in cancer and immunity. Cell Death Differ.2010; 17(4):616-23.
19. Topham NJ, Hewitt EW. Natural killer cell cytotoxicity: how do they pull the trigger? Immunology.2009; 128(1):7-15.
20. de Saint Basile G, Ménasché G, Fischer A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol.2010; 10(8):568-79.
21. Smyth MJ, Cretney E, Kelly JM et al. Activation of NK cell cytotoxicity. Mol Immunol. 2005; 42(4):501-10.
22. Man YG, Sang QX. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the 'proteasecentered' hypothesis. Exp Cell Res. 2004; 301: 103-18.
23. Yousefi M, Mattu R, Gao C, Man YG. Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: Implications for tumor progression and invasion. AIMM. 2005; 13:30-7.
24. Man YG, Shen T, Zhao YG, Sang QX. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion. Cancer Detect Prev. 2005; 29: 161-9.
25. Man YG. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion. Med Hypoth. 2007; 69: 1340-57.
26. Man YG, Gardner WA. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Med Hypoth. 2008; 70: 387-408.
27. Man YG, Harley R, Mason J, Gardner WA. Contributions of leukocytes to tumor invasion and metastasis: the "piggy-back" hypothesis. Cancer Epidem. 2010; 34: 3-6.
28. Man YG, Mason J, Harley R et al. Leukocyte-facilitated tumor dissemination: a novel model for tumor cell dissociation and metastasis. J Cell Biochem.2011; 112: 1154-67.
29. Man YG. Aberrant leukocyte infiltration: a direct trigger for breast tumor invasion and metastasis. Int J Biol Sci. 2010; 6(2):129-32.
30. Hsiao YH, Deng CX, Mason JT, Chou MC, Man YG. Hidden malignant cells within leukocyte aggregates in normal or hyperplastic tissues of pregnancy-associated breast cancer. Cancer Epidemiol. 2011; [Epub ahead of print].
31. Song G, Ren I, Stojadinovic A et al. Conjunction of tumor cells with lymphocytes: implications for tumor invasion and metastasis. Cancer Epidemiol. 2012; 36(4):354-63.
32. Man YG. Tumor cell budding from focally disrupted tumor capsule: a common pathway for all breast cancer subtype derived invasion? J Cancer. 2010; 1:27-31.
33. O'Brien JO, Lyons T, Bell KP et al. Alternatively activated macrophages and collagen I remodeling characterize the post-partum involuting mammary gland across species. Am J Pathol. 2010; 176: 1241-55.
34. Schedion P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer. 2006; 6(4):281-91.
35. Min Hu and Kornelia Polyak. Microenvironmental regulation of cancer development. Curr Opin Genet Dev. 2008; 18(1): 27-34.
36. Puspa Raj Pandey PR, Saidou J, Watabe K. Role of myoepithelial cells in breast tumor progression. Front Biosci. 2011; 15: 226-36.
37. Goldfarb RH, Liotta LA. Proteolytic enzymes in cancer invasion and metastasis. Semin Thromb Hemost. 1986; 12(4):294-307
38. Noffsinger A, Fenoglio-Preiser CM, Maru D, Gilinsky N. Gastrointestinal Diseases. Washington DC: American Registry of Pathology and Armed Forces Institute of Pathology. 2007.
39. Michor F, Iwasa Y, Rajagopalan H, Lengauer C, Nowak MA. Linear model of colon cancer initiation. Cell Cycle. 2004; 3(3):358-62.
40. Aaltonen LA. The multistep process of colon carcinogenesis. Cytokines Mol Ther.1996; 2(2): 111-4.
41. Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA. 2002; 99(23):15095-100.
42. Man YG, Burgar A. An antigen unmasking protocol that satisfies both immunohisto-chemical and subsequent molecular biological assessments. Pathol Res Pract 2003; 199: 815-25.
43. Uchida K, Kamikawa Y. Muscularis mucosae the forgotten sibling. J Smooth Muscle Res. 2007; 43(5):157-77.
44. Nagai K, Noguchi T, Hashimoto T, Uchida Y, Shimada T. The organization of the lamina muscularis mucosae in the human esophagus. Arch Histol Cytol. 2003; 66(3):281-8.
45. Yoshinaka H, Shimazu H, Fukumoto T, Baba M. Superficial esophageal carcinoma: a clinicopathological review of 59 cases. Am J Gastroenterol. 1991; 86(10):1413-8.
46. Araki K, Ohno S, Egashira A et al. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002; 94(2):570-5.
47. Csete M, Walikonis J, Slawny N. Oxygen-mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture. J Cell Physical. 2001; 189: 189-96.
48. Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol.2004; 92: 47-56
49. Klos KS, Wyszomierski SL, Sun M et al. c-erbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res. 2006; 6: 2028-2037
50. Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev.2005; 2(3):203-12.
51. Fevr T, Robine S, Louvard D, Huelsken J. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol. 2007; 27(21):7551-9.
52. Freeman HJ. Crypt region localization of intestinal stem cells in adults. World J Gastroenterol.2008; 14(47):7160-2.
53. Dhawan P, Ahmad R, Srivastava AS, Singh AB. Cancer stem cells and colorectal cancer: an overview. Curr Top Med Chem. 2011; 11(13):1592-8.
54. Buczacki S, Davies RJ, Winton DJ. Stem cell quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target. Br J Cancer. 2011; 105(9):1253-9.
55. Rizk P, Barker N. Gut stem cells in tissue renewal and disease: methods, markers, and myths. Wiley Interdiscip Rev Syst Biol Med. 2012; 4(5):475-96.
56. Forster SJ, Talbot IC, Clayton DG, Critchley DR. Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance. Int J Cancer.1986; 37(6):813-7.
57. Skovbjerg H, Anthonsen D, Lothe IM et al. Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer. 2009; 9:136.
58. Shinto E, Tsuda H, Ueno H et al. Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab Invest. 2005; 85(2):257-66.
59. Kirkland SC, Henderson K. Collagen IV synthesis is restricted to the enteroendocrine pathway during multilineage differentiation of human colorectal epithelial stem cells. J Cell Sci. 2001; 114(Pt 11):2055-64.
60. Kirkland SC. Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br J Cancer. 2009; 101(2):320-6.
61. Mauney J, Volloch V. Collagen I matrix contributes to determination of adult human stem cell lineage via differential, structural conformation-specific elicitation of cellular stress response. Matrix Biol. 2009; 28(5):251-62.
62. Schenke-Layland K, Angelis E, Rhodes KE et al. Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells. Stem Cells. 2007; 25(6):1529-38.
63. Lazaris ACh, Tzoumani AN, Thimara I et al. Immunohistochemical assessment of basement membrane components in colorectal cancer: prognostic implications. J Exp Clin Cancer Res. 2003; 22(4):599-606.
64. Valadi H, Ekstrom K, Bossios A et al. Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654-59.
65. Clarke SL, Betts GJ, Plant A et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLOS One. 2006; 1:e129.
66. Moinfar F, Man YG, Bratthauer GL et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (clinging ductal carcinoma in situ): a simulator of normal mammary epithelium. Cancer. 2000; 88(9):2072-81.
67. Malins DC, Gilman NK, Green VM. A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis. Proc Natl Acad Sci USA. 2005; 102: 19093-6.
68. Pentheroudakis G, Briasoulis E, Pavlidis N. Cancer of unknown primary site: missing primary or missing biology? Oncologist. 2007; 12(4):418-25.
69. Hanauske AR, Clark GM, Von Hoff DD. Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system. Invest New Drugs.1995; 13(1):43-9.
70. Stoyianni A, Goussia A, Pentheroudakis G et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012; 32(4):1273-81.
71. Alga AM, Rothwell PM. Effects of regular asprin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012; Epub ahead of print.